Quince Therapeutics, Inc. (QNCX)

1.15 -0.05 (-4.17%) USD  |  NASDAQ  |  May 27, 16:00
1.17 +0.02 (+1.74%) After-Hours: 20:00
More

Quince Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for QNCX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
BioXcel Therapeutics, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade